Cássia Rita Pereira da Veiga
4PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 14, 2021
Number needed to treat analysis applied to pembrolizumab plus chemotherapy for first-line treatment of non-squamous non-small cell lung cancer.Luciano Paladini, Cássia Rita Pereira da Veiga, Érica Cerqueira
|Mar 30, 2021
Cutaneous melanoma: cost of illness under Brazilian health system perspectives.Cassia Rita Pereira da Veiga, Claudimar Pereira da Veiga, Alceu Souza
|Feb 04, 2021
Pembrolizumab plus axitinib and nivolumab plus ipilimumab as first-line treatments of advanced intermediate- or poor-risk renal-cell carcinoma: a number needed to treat analysis from the Brazilian private perspective.Tobias Engel Ayer Botrel, Márcia Datz Abadi, Laura Chabrol Haas
|Jan 10, 2020
Facebook HPV vaccine campaign: insights from Brazil.Cássia Rita Pereira da Veiga, Elder Semprebon, Jacqueline Laurindo da Silva
Pageof 1
Frequent Collaborators
2 joint publications
Claudimar Pereira da Veiga
1 joint publications
Elder Semprebon
1 joint publications
Vinicius Lins Ferreira
1 joint publications
Tobias Engel Ayer Botrel
1 joint publications
Denis Leonardo Jardim
1 joint publications
Alberto Julius Alves Wainstein
1 joint publications
Andreia Cristina de Melo
1 joint publications
Ana Paula Drummond-Lage
1 joint publications
Luciano Paladini
1 joint publications
Érica Cerqueira
